Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-08

Clinical Trial Update: Esmolol vs. Labetalol in Endoscopic Sinus Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial comparing esmolol to labetalol in endoscopic sinus surgery for chronic sinusitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmolol (esmolol)
  • labetalol (labetalol hydrochloride)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Chronic Sinusitis | Phase 2 | Status: COMPLETED | Results posted: 2021-02-08